Membrane vesiculation protects erythrocytes from destruction by complement
- PMID: 1918984
Membrane vesiculation protects erythrocytes from destruction by complement
Abstract
Nucleated cells can resist attack by C by exocytosis or endocytosis of the terminal C components C5b-9 (membrane attack complex) (MAC), but it is generally accepted that formation of a single MAC channel on E leads to lysis (one-hit theory). We find that human and guinea pig E, but not SRBC, can eliminate the MAC from the membrane in the form of microvesicles and escape destruction. When guinea pig or human E are incubated with C5b-9, vesiculation proceeds without a lag and is detected at nonlytic doses of C9. Continuous Ca2+ influx is required for vesiculation. The amount of released vesicles is in direct relation to Ca2+ concentration, and the increase in vesiculation is associated with a parallel decrease in lysis. SRBC, which do not vesiculate when Ca2+ loaded, are lysed by C5b-9 with the same efficiency in the presence or absence of Ca2+. Vesicles released from guinea pig RBC under C5b-9 attack are enriched in C9 by a factor of 10, compared with the unlysed cells, and by a factor of 3 to 4, compared with ghosts. We conclude that E are protected from lysis not only by CD59 and C8bp/HRF, which prevent MAC assembly, but also by selective elimination of the MAC.
Similar articles
-
The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.J Immunol. 1990 May 1;144(9):3478-83. J Immunol. 1990. PMID: 1691760
-
A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.J Immunol. 1994 Feb 15;152(4):1927-34. J Immunol. 1994. PMID: 7509832
-
Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.J Immunol. 1984 Oct;133(4):2133-7. J Immunol. 1984. PMID: 6470486
-
Transmembrane channel-formation by five complement proteins.Biochem Soc Symp. 1985;50:235-46. Biochem Soc Symp. 1985. PMID: 2428370 Review.
-
Emission of membrane vesicles: roles in complement resistance, immunity and cancer.Springer Semin Immunopathol. 2005 Nov;27(3):375-87. doi: 10.1007/s00281-005-0004-1. Epub 2005 Nov 11. Springer Semin Immunopathol. 2005. PMID: 16189651 Review.
Cited by
-
Human red blood cells release microvesicles with distinct sizes and protein composition that alter neutrophil phagocytosis.J Extracell Biol. 2023 Nov;2(11):e107. doi: 10.1002/jex2.107. Epub 2023 Oct 25. J Extracell Biol. 2023. PMID: 37942280 Free PMC article.
-
Ectosomes as immunomodulators.Semin Immunopathol. 2011 Sep;33(5):487-95. doi: 10.1007/s00281-010-0232-x. Epub 2010 Dec 7. Semin Immunopathol. 2011. PMID: 21136061 Review.
-
Extracellular Vesicles: Packages Sent With Complement.Front Immunol. 2018 Apr 11;9:721. doi: 10.3389/fimmu.2018.00721. eCollection 2018. Front Immunol. 2018. PMID: 29696020 Free PMC article. Review.
-
HUS and atypical HUS.Blood. 2017 May 25;129(21):2847-2856. doi: 10.1182/blood-2016-11-709865. Epub 2017 Apr 17. Blood. 2017. PMID: 28416508 Free PMC article. Review.
-
Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells.Immunol Res. 2001;24(2):191-9. doi: 10.1385/ir:24:2:191. Immunol Res. 2001. PMID: 11594456 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous